Flurbiprofen and intraocular pressure

D. K. Gieser, E. Hodapp, I. Goldberg, M. A. Kass, B. Becker

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

Systemic or topical administration of corticosteroids may produce a rise in intraocular pressure (IOP). Nonsteroidal anti-inflammatory drugs (NSAI drugs) are alternative therapy for ocular inflammatory disease. Flurbiprofen, a new NSAI drug, was tested in double-masked fashion to delineate its effect on IOP. Flurbiprofen did not alter IOP in known high corticosteroid responders nor did it block corticosteroid-induced ocular hypertension.

Original languageEnglish (US)
Pages (from-to)831-833
Number of pages3
JournalAnnals of ophthalmology
Volume13
Issue number7
StatePublished - Dec 1 1981

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Flurbiprofen and intraocular pressure'. Together they form a unique fingerprint.

  • Cite this

    Gieser, D. K., Hodapp, E., Goldberg, I., Kass, M. A., & Becker, B. (1981). Flurbiprofen and intraocular pressure. Annals of ophthalmology, 13(7), 831-833.